Literature DB >> 18255010

Contrast-induced nephropathy: update with special emphasis on patients with diabetes.

Richard Solomon1.   

Abstract

Contrast-induced nephropathy (CIN) continues to be a significant complication of the increasing use of iodinated contrast media. There have been few new insights into pathogenesis; despite multiple strategies aimed at prophylaxis, very few have proven efficacious. This article reviews our current knowledge regarding CIN, with emphasis on patients with diabetes.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18255010     DOI： 10.1007/s11892-007-0077-4

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  24 in total

Review 1.  Contrast medium use.

Authors:  Charles Davidson; Fulvio Stacul; Peter A McCullough; James Tumlin; Andy Adam; Norbert Lameire; Christoph R Becker
Journal:  Am J Cardiol       Date:  2006-03-02       Impact factor: 2.778

2.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

3.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

Authors:  Peter Marckmann; Lone Skov; Kristian Rossen; Anders Dupont; Mette Brimnes Damholt; James Goya Heaf; Henrik S Thomsen
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

4.  Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.

Authors:  Carlo Briguori; Flavio Airoldi; Davide D'Andrea; Erminio Bonizzoni; Nuccia Morici; Amelia Focaccio; Iassen Michev; Matteo Montorfano; Mauro Carlino; John Cosgrave; Bruno Ricciardelli; Antonio Colombo
Journal:  Circulation       Date:  2007-02-19       Impact factor: 29.690

5.  Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.

Authors:  Giancarlo Marenzi; Gianfranco Lauri; Jeness Campodonico; Ivana Marana; Emilio Assanelli; Monica De Metrio; Marco Grazi; Fabrizio Veglia; Franco Fabbiocchi; Piero Montorsi; Antonio L Bartorelli
Journal:  Am J Med       Date:  2006-02       Impact factor: 4.965

Review 6.  Dialysis and iodinated contrast media.

Authors:  G Deray
Journal:  Kidney Int Suppl       Date:  2006-04       Impact factor: 10.545

Review 7.  Prevention of contrast-induced nephropathy with volume supplementation.

Authors:  C Mueller
Journal:  Kidney Int Suppl       Date:  2006-04       Impact factor: 10.545

8.  Nephrotoxic effects in high-risk patients undergoing angiography.

Authors:  Peter Aspelin; Pierre Aubry; Sven-Göran Fransson; Ruth Strasser; Roland Willenbrock; Knut Joachim Berg
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

9.  The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study.

Authors:  Alejandro Recio-Mayoral; Marinela Chaparro; Belén Prado; Rocío Cózar; Irene Méndez; Debasish Banerjee; Juan C Kaski; José Cubero; Jose M Cruz
Journal:  J Am Coll Cardiol       Date:  2007-03-12       Impact factor: 24.094

10.  Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.

Authors:  Richard J Solomon; Madhu K Natarajan; Serge Doucet; Samin K Sharma; Cezar S Staniloae; Richard E Katholi; Joseph L Gelormini; Marino Labinaz; Abel E Moreyra
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.